Perispinal Etanercept to improve STroke Outcomes (PESTO): Protocol for a multicenter, international, randomized placebo-controlled trial.

Vincent ThijsGeoffrey C CloudNigel GilchristBrooke ParsonsForum TilvawalaJan HoLara RuthnamVimal StanislausNikola SpriggMarion WalkerPhilip M BathLeonid ChurilovJulie Bernhardt

Published in: European stroke journal (2024)

PESTO aims to provide level 1 evidence on the safety and efficacy of perispinal etanercept in patients with long-term disabling effects of stroke.

Keyphrases

double blind
atrial fibrillation
rheumatoid arthritis
placebo controlled
ankylosing spondylitis
rheumatoid arthritis patients
juvenile idiopathic arthritis
clinical trial
randomized controlled trial
phase iii
open label
study protocol
phase ii
cross sectional
skeletal muscle
blood brain barrier
glycemic control